Report Detail

Pharma & Healthcare Dynamics in Post-pandemic Global Human Pluripotent Stem Cell Industry: Supply and Demand, Markets and Prices 2021-2027

  • RnM4304925
  • |
  • 13 April, 2021
  • |
  • Global
  • |
  • 129 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Human Pluripotent Stem Cell Market Status and Forecast (2016-2027)
      • 1.3.2 Global Human Pluripotent Stem Cell Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Human Pluripotent Stem Cell Supply by Company

    • 2.1 Global Human Pluripotent Stem Cell Sales Volume by Company
    • 2.2 Global Human Pluripotent Stem Cell Sales Value by Company
    • 2.3 Global Human Pluripotent Stem Cell Price by Company
    • 2.4 Human Pluripotent Stem Cell Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Human Pluripotent Stem Cell Market Status by Category

    • 3.1 Human Pluripotent Stem Cell Category Introduction
      • 3.1.1 Totipotent Stem Cells
      • 3.1.2 Pluripotent Stem Cells
      • 3.1.3 Unipotent Stem Cells
    • 3.2 Global Human Pluripotent Stem Cell Market by Category
      • 3.2.1 Global Human Pluripotent Stem Cell Sales Volume by Category (2016-2021)
      • 3.2.2 Global Human Pluripotent Stem Cell Sales Value by Category (2016-2021)
      • 3.2.3 Global Human Pluripotent Stem Cell Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Human Pluripotent Stem Cell Market Status by End User/Segment

    • 4.1 Human Pluripotent Stem Cell Segment by End User/Segment
      • 4.1.1 Research
      • 4.1.2 Clinical Trials
      • 4.1.3 Others
    • 4.2 Global Human Pluripotent Stem Cell Market by End User/Segment
      • 4.2.1 Global Human Pluripotent Stem Cell Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Human Pluripotent Stem Cell Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Human Pluripotent Stem Cell Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Human Pluripotent Stem Cell Market Status by Region

    • 5.1 Global Human Pluripotent Stem Cell Market by Region
      • 5.1.1 Global Human Pluripotent Stem Cell Sales Volume by Region
      • 5.1.2 Global Human Pluripotent Stem Cell Sales Value by Region
    • 5.2 North America Human Pluripotent Stem Cell Market Status
    • 5.3 Europe Human Pluripotent Stem Cell Market Status
    • 5.4 Asia Pacific Human Pluripotent Stem Cell Market Status
    • 5.5 Central & South America Human Pluripotent Stem Cell Market Status
    • 5.6 Middle East & Africa Human Pluripotent Stem Cell Market Status

    6 North America Human Pluripotent Stem Cell Market Status

    • 6.1 North America Human Pluripotent Stem Cell Market by Country
      • 6.1.1 North America Human Pluripotent Stem Cell Sales Volume by Country (2016-2021)
      • 6.1.2 North America Human Pluripotent Stem Cell Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Human Pluripotent Stem Cell Market Status

    • 7.1 Europe Human Pluripotent Stem Cell Market by Country
      • 7.1.1 Europe Human Pluripotent Stem Cell Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Human Pluripotent Stem Cell Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Human Pluripotent Stem Cell Market Status

    • 8.1 Asia Pacific Human Pluripotent Stem Cell Market by Country
      • 8.1.1 Asia Pacific Human Pluripotent Stem Cell Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Human Pluripotent Stem Cell Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Human Pluripotent Stem Cell Market Status

    • 9.1 Central & South America Human Pluripotent Stem Cell Market by Country
      • 9.1.1 Central & South America Human Pluripotent Stem Cell Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Human Pluripotent Stem Cell Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Human Pluripotent Stem Cell Market Status

    • 10.1 Middle East & Africa Human Pluripotent Stem Cell Market by Country
      • 10.1.1 Middle East & Africa Human Pluripotent Stem Cell Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Human Pluripotent Stem Cell Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Human Pluripotent Stem Cell Distributors
    • 11.3 Human Pluripotent Stem Cell Buyers

    12 Global Human Pluripotent Stem Cell Market Forecast by Category and by End User/Segment

    • 12.1 Global Human Pluripotent Stem Cell Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Human Pluripotent Stem Cell Forecast by Category
      • 12.2.1 Global Human Pluripotent Stem Cell Sales Volume Forecast by Category
      • 12.2.2 Global Human Pluripotent Stem Cell Sales Value Forecast by Category
      • 12.2.3 Global Human Pluripotent Stem Cell Price Forecast by Category
    • 12.3 Global Human Pluripotent Stem Cell Forecast by End User/Segment
      • 12.3.1 Global Human Pluripotent Stem Cell Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Human Pluripotent Stem Cell Sales Value Forecast by End User/Segment
      • 12.3.3 Global Human Pluripotent Stem Cell Price Forecast by End User/Segment

    13 Global Human Pluripotent Stem Cell Market Forecast by Region/Country

    • 13.1 Global Human Pluripotent Stem Cell Market Forecast by Region (2022-2027)
      • 13.1.1 Global Human Pluripotent Stem Cell Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Human Pluripotent Stem Cell Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 ESI BIO
      • 14.1.1 Company Information
      • 14.1.2 Human Pluripotent Stem Cell Product Introduction
      • 14.1.3 ESI BIO Human Pluripotent Stem Cell Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Thermo Fisher
      • 14.2.1 Company Information
      • 14.2.2 Human Pluripotent Stem Cell Product Introduction
      • 14.2.3 Thermo Fisher Human Pluripotent Stem Cell Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 TATAA Biocenter
      • 14.3.1 Company Information
      • 14.3.2 Human Pluripotent Stem Cell Product Introduction
      • 14.3.3 TATAA Biocenter Human Pluripotent Stem Cell Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Takara Bio
      • 14.4.1 Company Information
      • 14.4.2 Human Pluripotent Stem Cell Product Introduction
      • 14.4.3 Takara Bio Human Pluripotent Stem Cell Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Astellas Institute of Regenerative Medicine
      • 14.5.1 Company Information
      • 14.5.2 Human Pluripotent Stem Cell Product Introduction
      • 14.5.3 Astellas Institute of Regenerative Medicine Human Pluripotent Stem Cell Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 Fujifilm Cellular Dynamics
      • 14.6.1 Company Information
      • 14.6.2 Human Pluripotent Stem Cell Product Introduction
      • 14.6.3 Fujifilm Cellular Dynamics Human Pluripotent Stem Cell Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Viacyte, Inc.
      • 14.7.1 Company Information
      • 14.7.2 Human Pluripotent Stem Cell Product Introduction
      • 14.7.3 Viacyte, Inc. Human Pluripotent Stem Cell Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Asterias Biotherapeutics
      • 14.8.1 Company Information
      • 14.8.2 Human Pluripotent Stem Cell Product Introduction
      • 14.8.3 Asterias Biotherapeutics Human Pluripotent Stem Cell Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 UK Stem Cell Bank
      • 14.9.1 Company Information
      • 14.9.2 Human Pluripotent Stem Cell Product Introduction
      • 14.9.3 UK Stem Cell Bank Human Pluripotent Stem Cell Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 Reliance Life Sciences
      • 14.10.1 Company Information
      • 14.10.2 Human Pluripotent Stem Cell Product Introduction
      • 14.10.3 Reliance Life Sciences Human Pluripotent Stem Cell Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 Contact Information
    • 14.11 PerkinElmer
    • 14.12 STEMCELL Technologies
    • 14.13 R&D Systems (Biotrchne)
    • 14.14 MilliporeSigma (Merck)
    • 14.15 BD Biosciences
    • 14.16 BioTime

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Human Pluripotent Stem Cell market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Human Pluripotent Stem Cell market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Totipotent Stem Cells
    Pluripotent Stem Cells
    Unipotent Stem Cells

    Segmented by End User/Segment
    Research
    Clinical Trials
    Others

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    ESI BIO
    Thermo Fisher
    TATAA Biocenter
    Takara Bio
    Astellas Institute of Regenerative Medicine
    Fujifilm Cellular Dynamics
    Viacyte, Inc.
    Asterias Biotherapeutics
    UK Stem Cell Bank
    Reliance Life Sciences
    PerkinElmer
    STEMCELL Technologies
    R&D Systems (Biotrchne)
    MilliporeSigma (Merck)
    BD Biosciences
    BioTime


    Summary:
    Get latest Market Research Reports on Human Pluripotent Stem Cell. Industry analysis & Market Report on Human Pluripotent Stem Cell is a syndicated market report, published as Dynamics in Post-pandemic Global Human Pluripotent Stem Cell Industry: Supply and Demand, Markets and Prices 2021-2027. It is complete Research Study and Industry Analysis of Human Pluripotent Stem Cell market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,980.00
    $4,470.00
    $5,960.00
    2,145.60
    3,218.40
    4,291.20
    2,470.42
    3,705.63
    4,940.84
    325,803.40
    488,705.10
    651,606.80
    220,251.80
    330,377.70
    440,503.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report